Results: 10

Novedades en el calendario de vacunas de Argentina. Tercera parte: neumococo
News in Argentina’s vaccine schedule. Third part: pneumococcus

A fines de 2023 la autoridad sanitaria de Argentina realizó modificaciones en el Calendario Nacional obligatorio, que serán implementadas en forma progresiva durante 2024. Este artículo está enfocado en el reemplazo progresivo de las vacunas antineumocóccicas conjugada de 13 serotipos y polisacárid...

Theoretical pneumococcal vaccine coverage: analysis of serotypes isolated from inpatients at a tertiary care hospital

J. bras. pneumol; 44 (5), 2018
ABSTRACT Objective: To evaluate Streptococcus pneumoniae serotypes isolated from an inpatient population at a tertiary care hospital, in order to determine the theoretical coverage of the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPV23). Met...

Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: vaccination impact

ABSTRACT Objective To measure the effectiveness of pneumococcal conjugated vaccine (PCV13) against Community Acquired Pneumonia (CAP) and invasive pneumococcal disease, 2 years after the vaccine (2+1) was included into the National Immunization Program of Argentina, and to describe variables associated ...

Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria

Braz. j. infect. dis; 21 (4), 2017
Abstract The 10-valent pneumococcal conjugate vaccine (PCV10) has been included in Bulgarian Childhood Immunization Program since 2010. This study aimed to assess serotype distribution and antimicrobial resistance of 198 invasive and non-invasive Streptococcus pneumoniae strains that had been isolated in...

Estudio funcional de la respuesta inmune a vacunas anti neumocóccicas
Evaluation of functional immune response to pneumococcal vaccines

Rev. chil. infectol; 16 (supl. 1), 1999
Los estudios descritos usan fagocitos cultivables, los cuales ayudan a la estandarización de un ensayo de fagocitos que puede medir repetitivamente la respuesta inmune de anticuerpos funcionales. La opsonofagocitosis parece ser un sustituto apropiado de la protección in vivo, ya que muestra una buena c...

Dosagem de níveis de anticorpos contra polissacarídeos capsulares de Streptococcus pneumoniae após vacinaçäo de pacientes HIV positivos com vacina pneumocócica 23-valente

Streptococcus pneumoniae é o agente causal mais comum de pneumonias bacterianas e bacteremias nao micobacterianas em indivíduos infectados pelo HIV, estimando-se que esses pacientes sejam de 100 a 300 vezes mais susceptíveis à doença pneumocóccica invasiva, se comparados a indivíduos nao infectado...

Actividad in vitro de agentes antimicrobianos selectos frente a cepas de Neisseria gonorrhoese, streptococcus pneumoniae y streptococcus beta - hemolítico

Las acividades in vitro de diez agentes antimicrobianos incluyendo a la Penicilina, Ampicilina, Cefalotina, Imipenem, Tetraciclina, Eritromicina, Trimetoprim-Sulfametoxazole, Gentamicina, y un nuevo agente B-lactámico (Imipenem) y dos nuevas quinolonas (Norfloxacina y Ciprofloxacina), fueron comparadas ...